ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

EIGR Eiger BioPharmaceuticals Inc

1,725
0,00 (0,00%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Eiger BioPharmaceuticals Inc EIGR NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 1,725 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,725 1,725
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.4.202417:12GLOBEEiger BioPharmaceuticals Files for Voluntary Chapter 11..
11.3.202421:03EDGAR2Form 8-K - Current report
24.1.202422:59EDGAR2Form 8-K - Current report
18.1.202423:49PRNUSEiger and Partner, AnGes, Receive Approval for Zokinvy®..
08.1.202413:00EDGAR2Form 8-K - Current report
04.1.202414:45EDGAR2Form 8-K - Current report
04.1.202414:00PRNUSEiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse..
11.12.202322:01EDGAR2Form DEF 14A - Other definitive proxy statements
04.12.202312:01EDGAR2Form SC 13D/A - General statement of acquisition of..
01.12.202322:02EDGAR2Form PRE 14A - Other preliminary proxy statements
24.11.202312:01EDGAR2Form SC 13D - General statement of acquisition of beneficial..
13.11.202322:01EDGAR2Form 8-K - Current report
09.11.202322:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202322:14EDGAR2Form 8-K - Current report
09.11.202322:05PRNUSEiger BioPharmaceuticals Reports Third Quarter 2023..
03.11.202302:54EDGAR2Form SC 13D/A - General statement of acquisition of..
03.11.202302:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.10.202321:51EDGAR2Form 3 - Initial statement of beneficial ownership of..
20.10.202322:29EDGAR2Form SC 13D - General statement of acquisition of beneficial..
28.9.202322:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12.9.202323:17DJNEiger BioPharmaceuticals to Discontinue Chronic Hepatitis..
12.9.202322:42EDGAR2Form 8-K - Current report
12.9.202322:05PRNUSEiger to Discontinue Phase 3 LIMT-2 Trial of Peginterferon..
06.9.202303:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.9.202303:35EDGAR2Form 3 - Initial statement of beneficial ownership of..
05.9.202322:05PRNUSEiger BioPharmaceuticals to Present at H.C. Wainwright 25th..
15.8.202312:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14.8.202322:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14.8.202322:09EDGAR2Form 8-K - Current report
14.8.202322:05PRNUSEiger BioPharmaceuticals Reports Second Quarter 2023..
28.7.202322:17EDGAR2Form 8-K - Current report
07.7.202322:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06.7.202323:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.6.202322:16EDGAR2Form 8-K - Current report
29.6.202314:00PRNUSEiger BioPharmaceuticals to Focus on Metabolic Diseases with..
28.6.202322:05PRNUSEiger BioPharmaceuticals to Host Business Update Call..
11.5.202322:00PRNUSEiger BioPharmaceuticals Reports First Quarter 2023..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock